KRAS and colorectal cancer: On the other hand, the frequency of KRAS mutations in appendiceal cancers (51%; with a maximum of 56% in adenocarcinomas) is close to that in colorectal cancers (51.8%) and small bowel cancers (53.6%), but much higher compared to gastric cancers (14.2%).